Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity.

Citation data:

Obesity reviews : an official journal of the International Association for the Study of Obesity, ISSN: 1467-789X, Vol: 19, Issue: 3, Page: 396-405

Publication Year:
2018
Usage 1
Abstract Views 1
Social Media 1
Tweets 1
Citations 3
Citation Indexes 3
Repository URL:
https://ro.uow.edu.au/ihmri/1261
PMID:
29119689
DOI:
10.1111/obr.12638
Author(s):
Huang, Xu-Feng; Weston-Green, Katrina; Yu, Y
Publisher(s):
Wiley-Blackwell
Tags:
Medicine; decreased; 5‐ht2cr; interaction; ghsr1a; antipsychotic; obesity; drug‐induced; Medicine and Health Sciences
Most Recent Tweet View All Tweets
review description
Second generation antipsychotics (SGAs), notably atypical antipsychotics including olanzapine, clozapine and risperidone, can cause weight gain and obesity side effects. Antagonism of serotonin 2c receptors (5-HT2cR) and activation of ghrelin receptor type 1a (GHSR1a) signalling have been identified as a main cause of SGA induced obesity. Here we review the pivotal regulatory role of the 5-HT2cR in ghrelin-mediated appetite signalling. The 5-HT2cR dimerizes with GHSR1a to inhibit orexigenic signalling, while 5-HT2cR antagonism reduces dimerization and increases GHSR1a-induced food intake. Dimerization is specific to the unedited 5-HT2cR isoform. 5-HT2cR antagonism by SGAs may disrupt the normal inhibitory tone on the GHSR1a, increasing orexigenic signalling. The 5-HT2cR and its interaction with the GHSR1a could serve as the basis for discovering novel approaches to preventing and treating SGA-induced obesity.